D. White

F. Marincola, D. Venzon, D. White, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens

S. Rosenberg, P. Hwu, J. Yang, 2003, Journal of immunotherapy.

Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

S. Rosenberg, P. Hwu, J. Yang, 2003, Human gene therapy.

Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA‐Cw*0702‐associated epitope MAGE‐A12:170–178

F. Marincola, S. Mocellin, D. White, 2003, International journal of cancer.

Immunization of HLA-A*0201 and/or HLA-DPβ1*04 Patients with Metastatic Melanoma Using Epitopes from the NY-ESO-1 Antigen

S. Rosenberg, J. Yang, S. Topalian, 2004, Journal of immunotherapy.

Study on Adoptive Immunotherapy Using Gene-Modified TCells for Ovarian Cancer

S. Rosenberg, P. Hwu, S. Canevari, 2006 .

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

S. Rosenberg, I. Lowy, J. Yang, 2007, Journal of immunotherapy.

Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

S. Steinberg, S. Rosenberg, J. Yang, 2010, Journal of immunotherapy.

Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients.

S. Rosenberg, N. Young, L. Platanias, 1987, Blood.

Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.

A. K. Srivastava, M. Raffeld, S. Rosenberg, 2017, The Lancet. Oncology.

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

S. Steinberg, W. Linehan, S. Rosenberg, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy

S. Rosenberg, J. Butman, J. Yang, 2010, Clinical Cancer Research.

Patterns of recurrence in patients with high-grade soft-tissue sarcomas.

S. Rosenberg, T. Kinsella, D. White, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience with the Use of High‐Dose Interleukin‐2 in the Treatment of 652 Cancer Patients

W. Linehan, S. Rosenberg, M. Lotze, 1989, Annals of surgery.

Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma

S. Rosenberg, J. Yang, D. White, 2021, Clinical Cancer Research.

Treatment of metastatic uveal melanoma with adoptive transfer of tumor infiltrating lymphocytes: a single-center phase 2 study

A. K. Srivastava, M. Raffeld, S. Rosenberg, 2017 .

Assessment of Ovarian Function After Preparative Chemotherapy and Total Body Radiation for Adoptive Cell Therapy

S. Rosenberg, J. Yang, D. White, 2011, Journal of immunotherapy.

VivoPartial Reduction in Regulatory T Cells In Metastatic Melanoma Induces a Selective Immunotoxin, LMB-2, to Patients with Administration of a CD25-Directed

I. Pastan, M. Merino, S. Rosenberg, 2007 .

Administration of a CD25-Directed Immunotoxin, LMB-2, to Patients with Metastatic Melanoma Induces a Selective Partial Reduction in Regulatory T Cells In Vivo1

I. Pastan, M. Merino, S. Rosenberg, 2007, The Journal of Immunology.

Viruses Encoding the Anchor-modified gp 100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma

S. Rosenberg, P. Hwu, J. Yang, 2003 .

Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.

B. Garra, S. Steinberg, J. Hoofnagle, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice

R. Cardiff, S. Dedhar, W. Muller, 2001, Oncogene.

Management and Outcome of Patients With Sporadic Gastrinoma Arising in the Duodenum

S. Libutti, J. Norton, R. Jensen, 2003, Annals of surgery.

Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.

S. Rosenberg, D. Lee, D. White, 1998, The cancer journal from Scientific American.

Trends in the safety of high dose bolus interleukin‐2 administration in patients with metastatic cancer

S. Rosenberg, D. White, U. Kammula, 1998, Cancer.

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer.

S. Steinberg, W. M. Linehan, A. Belldegrun, 1987, Annals of internal medicine.

Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure.

S. Nattel, J. Tardif, S. Dedhar, 2006, Genes & development.

Safety and Efficacy of High-Dose Interleukin-2 Therapy in Patients With Brain Metastases

S. Steinberg, S. Rosenberg, J. Yang, 2002, Journal of immunotherapy.

Durability of Complete Responses in Patients With Metastatic Cancer Treated With High-Dose Interleukin-2. Identification of the Antigens Mediating Response

S. Steinberg, S. Rosenberg, J. Yang, 1999 .

Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas.

S. Steinberg, A. Chang, D. White, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of polyethylene glycol‐modified interleukin‐2 (PEG‐IL‐2) in the treatment of patients with metastatic renal cell carcinoma and melanoma

F. Marincola, S. Rosenberg, J. Yang, 1995, Cancer.

Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.

S. Steinberg, S. Topalian, D. White, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized S tudy o f H igh-Dose a nd L ow-Dose I nterleukin-2 in P atients W ith M etastatic R enal C ancer

S. Steinberg, M. Merino, S. Rosenberg, 2003 .

a Peptide Vaccine Patients with Metastatic Melanoma Receiving Generation of Antitumor Reactivity in Impact of Cytokine Administration on the

F. Marincola, S. Rosenberg, P. Hwu, 1999 .

A Prospective Randomized Trial Evaluating Colloid Versus Crystalloid Resuscitation in the Treatment of the Vascular Leak Syndrome Associated with Interleukin‐2 Therapy

S. Steinberg, S. Rosenberg, M. Lotze, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma.

S. Steinberg, F. Marincola, S. Rosenberg, 1996, The cancer journal from Scientific American.

A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.

S. Steinberg, H. Langstein, J. Norton, 1992, Surgery.

Cardiopulmonary toxicity of treatment with high dose interleukin‐2 in 199 consecutive patients with metastatic melanoma or renal cell carcinoma

S. Rosenberg, D. White, D. Schwartzentruber, 1994, Cancer.

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth

E. Andrechek, W. Muller, D. White, 2005, Oncogene.

Combination therapy with interferon-γ and interleukin-2 for the treatment of metastatic melanoma

F. Marincola, J. Taubenberger, S. Rosenberg, 1996 .

The hematologic toxicity of interleukin‐2 in patients with metastatic melanoma and renal cell carcinoma

S. Rosenberg, J. Yang, D. White, 1995, Cancer.

Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma.

S. Steinberg, S. Topalian, D. White, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

for Combination Metastatic Colorectal Cancer Using 5Fluorouracil, Leucovorin and Interleukin-2

E. Shlasko, S. Rosenberg, J. Yang, 1993 .

Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses.

S. Steinberg, S. Rosenberg, B. Pockaj, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2.

E. Shlasko, S. Rosenberg, J. Yang, 1993, European journal of cancer.

Thyroid dysfunction associated with immunotherapy for patients with cancer

M. Zweig, B. Weintraub, S. Rosenberg, 1991, Cancer.

Determinants of survival in patients with unresectable colorectal liver metastases

S. Steinberg, A. Chang, D. White, 1989, Journal of surgical oncology.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

S. Rosenberg, J. Yang, S. Topalian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thyroid Dysfunction in 281 Patients with Metastatic Melanoma or Renal Carcinoma Treated with Interleukin‐2 Alone

S. Steinberg, B. Weintraub, S. Rosenberg, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.

S. Rosenberg, J. Yang, S. Topalian, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Development of Gene Therapy for the Treatment of Cancer

S. Rosenberg, W. Anderson, P. Hwu, 1993, Annals of surgery.

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.

M. Sanda, M. Lotze, S. Topalian, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma.

D. Venzon, S. Rosenberg, T. Delaney, 1991, International journal of radiation oncology, biology, physics.

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

S. Rosenberg, D. White, M. Dudley, 2009, Blood.

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

John Mao, Francesco M Marincola, F. Marincola, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.

S. Steinberg, F. Marincola, S. Rosenberg, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.

S. Steinberg, S. Rosenberg, D. White, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.

S. Rosenberg, C. Klebanoff, J. Yang, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Gang Wang, Steven A. Rosenberg, Zelig Eshhar, 2006, Clinical Cancer Research.

Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

S. Steinberg, S. Rosenberg, J. Yang, 2007, Clinical Cancer Research.

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.

F. Marincola, S. Rosenberg, P. Hwu, 1998, Journal of the National Cancer Institute.

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

S. Rosenberg, J. Yang, S. Topalian, 1994, JAMA.

High‐grade soft tissue sarcomas of the extremities

S. Rosenberg, T. Kinsella, D. White, 1986, Cancer.

Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

W. Muller, S. Blaess, D. White, 2004, Cancer cell.

Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities.

S. Rosenberg, D. White, C. Seipp, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

Seth M Steinberg, S. Steinberg, S. Rosenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

F. Marincola, D. Venzon, S. Rosenberg, 1992, Cancer research.

Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation

S. Rosenberg, D. Citrin, J. Yang, 2014, Cancer.

High‐grade retroperitoneal sarcomas: Role of an aggressive palliative approach

A. Szold, D. White, H. Freund, 1993, Journal of surgical oncology.

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.

S. Steinberg, M. Merino, S. Rosenberg, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma

S. Rosenberg, J. Yang, D. White, 2012, Clinical Cancer Research.

In Vivo Analysis of Alternative Modes of Breast Cancer Cell Invasion

D. White, 2008 .

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.

W. Linehan, M. Walther, S. Rosenberg, 2001, The Journal of urology.

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response.

S. Steinberg, S. Rosenberg, J. Yang, 1998, Annals of surgery.

Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial

S. Steinberg, S. Rosenberg, J. Yang, 2014, Annals of Surgical Oncology.

Cytotoxic T lymphocyte-associated antigen 4 blockade with ipilimumab: Long-term follow-up of 179 patients with metastatic melanoma.

S. Rosenberg, J. Yang, D. White, 2010 .

Multifaceted Roles of Integrins in Breast Cancer Metastasis

W. Muller, D. White, 2007, Journal of Mammary Gland Biology and Neoplasia.

Aurora A kinase regulates mammary epithelial cell fate by determining mitotic spindle orientation in a Notch-dependent manner.

D. White, A. Mccarthy, T. Sourisseau, 2013, Cell reports.

Combination therapy with interferon alfa-2a and interleukin-2 for the treatment of metastatic cancer.

S. Rosenberg, D. White, F. Marincola, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

S. Steinberg, S. Rosenberg, J. Yang, 2008, Clinical Cancer Research.

Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experience.

S. Rosenberg, Leandro Mercedes, D. Schrump, 2010, The Journal of thoracic and cardiovascular surgery.

Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

S. Steinberg, F. Marincola, S. Rosenberg, 2014, Clinical Cancer Research.

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

S. Steinberg, S. Rosenberg, S. Topalian, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma

S. Steinberg, S. Rosenberg, M. Gonzales, 2006, Clinical Cancer Research.

Toxicity Studies of Adjuvant Intravenous Versus Intraperitoneal 5‐FU in Patients with Advanced Primary Colon or Rectal Cancer

D. White, I. Barofsky, P. Sugarbaker, 1986, American journal of clinical oncology.

Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy

S. Steinberg, S. Libutti, S. Rosenberg, 2009, Annals of Surgical Oncology.

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.

F. Marincola, S. Rosenberg, P. Hwu, 1999, Journal of immunology.

Acute and long term effects on limb function of combined modality therapy in patients treated with limb sparing surgery for soft tissue sarcoma of the extremity

D. Venzon, S. Rosenberg, T. Delaney, 1990 .

Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients

S. Rosenberg, J. Yang, D. White, 2017, Annals of Surgical Oncology.

Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place.

W. Linehan, M. Walther, S. Rosenberg, 1999, The Journal of urology.

Factors A ssociated W ith R esponse t o H igh-Dose Interleukin-2 i n P atients W ith M etastatic M elanoma

S. Steinberg, S. Rosenberg, D. White, 2001 .

Decreased Tolerance to Interleukin-2 With Repeated Courses of Therapy in Patients With Metastatic Melanoma or Renal Cell Cancer

S. Steinberg, S. Rosenberg, D. White, 2000, Journal of immunotherapy.

Altered CD8+ T-Cell Responses When Immunizing With Multiepitope Peptide Vaccines

S. Rosenberg, J. Yang, S. Topalian, 2006, Journal of immunotherapy.

Clinical Cancer esearch cer Therapy : Clinical cessful Treatment of Melanoma Brain R astases with Adoptive Cell Therapy

S. Rosenberg, J. Butman, J. Yang, 2010 .

astases with Adoptive Cell Therapy

S. Rosenberg, J. Butman, J. Yang, 2010 .

Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?

S. Rosenberg, J. Heiss, D. Lee, 1999, Journal of immunotherapy.

Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma

S. Rosenberg, Suzanne Inchauste, D. White, 2012, World Journal of Surgical Oncology.

Addressing the Role of Cell Adhesion in Tumor Cell Dormancy

W. Muller, D. White, J. Rayment, 2006, Cell cycle.

Water-soluble vitamins in cancer patients on parenteral nutrition: a prospective study.

J. Norton, M. Brennan, D. White, 1987, JPEN. Journal of parenteral and enteral nutrition.

Calcium and Phosphorus Metabolism During Total Parenteral Nutrition

D. White, G. Sloan, 1983, Annals of surgery.

A Pilot Study of Antiangiogenic Therapy with Bevacizumab and Thalidomide in Patients with Metastatic Renal Cell Carcinoma

S. Steinberg, S. Rosenberg, J. Yang, 2004, Journal of immunotherapy.

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

W. M. Linehan, W. Linehan, A. Chang, 1987, The New England journal of medicine.

Phase I S tudy o f t he I ntravenous A dministration o f Attenuated Salmonella t yphimurium to P atients W ith Metastatic M elanoma

F. Marincola, S. Rosenberg, P. Hwu, 2002 .

Award Number: W81XWH-07-1-0349 TITLE: In Vivo Analysis of Alternative Modes of Breast Cancer Cell Invasion

Principal Investigator, D. White, 2008 .

Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer.

S. Steinberg, W. Linehan, A. Chang, 1993, Journal of the National Cancer Institute.

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

S. Rosenberg, D. Solomon, M. Lotze, 1988, The New England journal of medicine.

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.

S. Steinberg, S. Rosenberg, D. Citrin, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

S. Steinberg, S. Rosenberg, D. White, 2010, Journal of immunotherapy.